Retatrutide, a new injectable drug candidate from Eli Lilly, is delivering stunning weight loss in clinical trials.
Doctors are comparing the results so far to bariatric surgery, calling it the “triple G.”
“Their mind is freed from the burden of trying to control every morsel of food” one doctor said.
(Credit: iStock)